The novel therapy of this peptide represents a significant advance in the care of the condition. Different to existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – resulting in improved sugar regulation and anticipated reduction in weight. Scientists are exploring its fu